-
oa Editorial [Hot topic: Low Grade Inflammation as a Common Pathogenetic Denominator in Age-Related Diseases: Novel Drug Targets for Anti-Ageing Strategies and Successful Ageing Achievement. Part II (Executive Editors: Calogero Caruso, Thea Magrone and Emilio Jirilllo)]
- Source: Current Pharmaceutical Design, Volume 16, Issue 7, Mar 2010, p. 753 - 753
-
- 01 Mar 2010
- Previous Article
- Table of Contents
- Next Article
Abstract
Part II of the above mentioned hot topic will focus on the pathogenesis of cardiovascular events; the molecular bases of longevity, and diet and ageing. Panaro and associates [1], Panaro and associates [2], Nicita-Mauro and associates [3], Forte and associates [4], Licastro and associates [5] and Bennati and associates [6] will point out the molecular bases for the cardiovascular risk, even including infections, smoking and metabolic syndrome. Singh and associates [7] and Cevenini and associates [8] will emphasize the role of HSP 70 as well as innovative anti-ageing targets to favor longevity, respectively. De Lorenzo and associates [9], Russo and associates [10], Barbagallo and Dominguez [11], Carbonelli and associates [12], Linsalata and associates [13], Amati and associates [14], Jirillo and associates [15], Amati and associates [16], Jirillo and associates [17], Calabrese and associates [18], Sikora and associates [19], and Amati and associates [20] will point out the major dietary approaches to prevent ageing or ameliorate its status by means of several types of nutraceuticals endowed with antioxidant and/or immunomodulating properties. >